Stage II Triple-Negative Breast Cancer: Nahilys's Patient Story

Patient Info: Nahilys | Stage II

Biomarkers: Triple-negative breast cancer.

Nahilys said she was well after treatment and continued surveillance every six months for triple-negative breast cancer.

Our Cancer StoriesRead more →

Hormone-dependent bifocal invasive lobular breast cancer with nodule disappearance after follow-up

Patient Info: Anonymized, Female, 50s

Biomarkers: Hormone-dependent; grade II

A 59-year-old patient with hormone-dependent grade II bifocal invasive lobular carcinoma reported nodule shrinkage after 9 months and disappearance of both nodules on ultrasound and mammogram after 12 months, while continuing 3-monthly monitoring.

BRCA1 Breast Cancer: Jasmin's Patient Story

Patient Info: Jasmin Nussing, Female, Under 40

Biomarkers: BRCA1 mutation

Jasmin completed major breast cancer treatment while continuing technical school, had BRCA1-related long-term risk management ahead, and required ongoing heart monitoring related to antibody/immunotherapy.

Krankheitserfahrungen.deRead more →

Breast Cancer: Waltraud's Survivor Story

Patient Info: Waltraud Amann, Female, 60s

Waltraud lived more than 18 years after her first breast cancer, experienced a right-axillary recurrence, returned to work through a gradual model, and managed long-term lymphoedema and menopausal symptoms during survivorship.

Krankheitserfahrungen.deRead more →

Breast Cancer: Susanne's Survivor Story

Patient Info: Susanne Ricke, Female, 60s

In the July 2023 interview, Susanne had completed breast-conserving surgery and 16 radiation treatments, had returned from rehabilitation, felt physically well, and continued regular follow-up with anxiety before appointments.

Krankheitserfahrungen.deRead more →

Breast Cancer: Ulrike's Survivor Story

Patient Info: Ulrike Blessinger, Female, 40s

Ulrike completed surgery, re-operation, radiation, and a short course of hormone therapy that was stopped after 6 months due to migraines and neurodermatitis; she later focused on follow-up, art, nature, nutrition, and quality of life.

Krankheitserfahrungen.deRead more →

Stage I Breast Cancer: Béatrice's Survivor Story

Patient Info: Béatrice, Female | Stage I

Béatrice had very early breast cancer detected at 2 mm, treated with mastectomy and immediate reconstruction, with no chemotherapy, radiation, or hormone therapy needed and return to work after 9 weeks.

Fondation ARCRead more →

Male breast cancer recurrence treated with surgery and long-term follow-up story

Patient Info: Anonymized, Male

More than 10 years after initial surgery and after a second surgery for recurrence about 3 years later, the latest 6-month check-up showed no abnormality and follow-up continued.

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Stage I Breast Cancer: Vanessa's Survivor Story

Patient Info: Vanessa Cuccurullo, Female | Stage I

Clear post-surgery mammogram/check-up after Stage I breast cancer treatment, healed reconstruction and reduction, and return to annual monitoring.

breastcancer.orgRead more →

Stage I Breast Cancer: Rosanna's Survivor Story

Patient Info: Rosanna Silber, Female, Under 40 | Stage I

Rosanna had no evidence of cancer after treatment for Stage I breast cancer and later cervical cancer, with ongoing checkups every 6 months for cervical cancer and annually for breast cancer.

Memorial Sloan KetteringRead more →

Stage IV Breast Cancer: Amy's Survivor Story

Patient Info: Amy Mannarino, Female, 50s | Stage IV

Metastatic Site: Brain

After brain metastasis surgery and 3 radiation sessions, Amy was doing well with no evidence of disease; the source specifically distinguishes NED from being cured or cancer-free in the setting of metastatic disease.

Memorial Sloan KetteringRead more →

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan KetteringRead more →

HER2-Positive Breast Cancer: Jim's Patient Story

Patient Info: Jim Keegan, Male, 70+

Biomarkers: HER2-positive; BRCA1/BRCA2 negative

Jim completed surgery, chemotherapy and 1 year of Herceptin for early-stage HER2-positive male breast cancer, then continued tamoxifen and yearly MSK surveillance while advocating for male breast cancer awareness.

Memorial Sloan KetteringRead more →

Stage I Breast Cancer: Michelle's Survivor Story

Patient Info: Michelle Kang, Female, Under 40 | Stage I

Biomarkers: Hormone-positive breast cancer; no suspicious inherited genetic mutation reported

Michelle was 6 years cancer-free after Stage 1B hormone-positive breast cancer while continuing hormone therapy, Zometa, Signatera blood testing, reconstruction follow-up, and survivorship monitoring.

City of HopeRead more →

Stage II Invasive Ductal Carcinoma: Margaret's Survivor Story

Patient Info: Margaret, Female | Stage II

Biomarkers: Onco-typing score 18; hormone-responsive tumor described; exact receptor status not reported

As of June 2026, Margaret’s story described completed surgery, chemotherapy, radiation, and later reconstruction for Stage II IDC/DCIS breast cancer, with survivorship focused on recovery, neuropathy, and integrative support rather than an explicit NED claim.

The Patient StoryRead more →

Stage 0 HR-Positive Invasive Ductal Carcinoma: Natalie's Survivor Story

Patient Info: Natalie, Female | Stage 0

Biomarkers: ER-positive

As of June 2026, Natalie was living after Stage 0 DCIS, later nipple/Paget's disease recurrence, and 20 surgeries through May 2019, with a full life and ongoing attention to physical changes after reconstruction.

The Patient StoryRead more →

Stage II BRCA1 Breast Cancer: Joy's Survivor Story

Patient Info: Joy R., Female | Stage II

Biomarkers: BRCA1 mutation

As of June 2026, Joy had no evidence of disease after chemotherapy, double mastectomy, and hysterectomy for Stage II breast cancer with a BRCA1 mutation, and had moved from 3-month to 6-month oncology monitoring.

The Patient StoryRead more →

BRCA2 Breast Cancer: Erika's Patient Story

Patient Info: Erika, Female, Under 40

Biomarkers: BRCA2 mutation

As of June 2026, Erika had no cancer diagnosis after a BRCA2-positive result and preventive double mastectomy with implant reconstruction, with ongoing hereditary-risk surveillance.

The Patient StoryRead more →

Stage I Invasive Lobular Carcinoma: Tammy's Survivor Story

Patient Info: Tammy, Female, 60s | Stage I

As of October 2025, Tammy had fully recovered and remained disease-free after Stage I invasive lobular breast cancer treated with partial mastectomy and a targeted week-long radiation course, with ongoing follow-up monitoring.

Cleveland ClinicRead more →

Stage II Triple-Negative Breast Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rancik, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

Jennifer entered remission in October 2017 after Stage II triple-negative breast cancer treatment and, as of October 2025, reported doing great and being off medications except occasional Zometa.

City of HopeRead more →

Paget disease, bilateral apocrine breast carcinomas, and primary breast follicular lymphoma after aromatase inhibition

Patient Info: Anonymized, Female, 70+

Biomarkers: Initial breast cancer was ER/PR-positive, HER2-negative. Later apocrine cancers were triple-negative with AR/ER-beta markers. Lymphoma had IgH::BCL2.

As of September 2025, she was alive 3 years after bilateral mastectomy and observation for Stage Ie follicular lymphoma, with no recurrence of either breast carcinoma or lymphoma.

PubMed CentralRead more →

Breast Cancer: Dolly's Survivor Story

Patient Info: Dolly Chua, Female

As of July 2025, Dolly had completed surgery for breast and thyroid tumors, described feeling wonderful and strong, and remained connected to follow-up care; the source does not explicitly state NED or recurrence status.

City of HopeRead more →

HR-Positive Breast Cancer: Sara's Patient Story

Patient Info: Sara Glenn, Female, Under 40

Biomarkers: TP53 mutation / Li-Fraumeni syndrome; ER-positive; HER2-negative

As of June 2025, Sara had completed bilateral mastectomy and reconstruction for ER-positive, HER2-negative breast cancer and was on planned 10-year tamoxifen plus intensive Li-Fraumeni syndrome surveillance for herself and her daughters.

City of HopeRead more →